(function(){var loadHandler=window['sl_{EC00A760-FAC2-48CD-8603-FA3C7FB92E6B}'];loadHandler&&loadHandler(11, '<div id="spr0_36535a3"><div id="spr1_36535a3" class="kern slide"><img id="img3_36535a3" src="data/img9.png" width="1280px" height="720px" alt="" style="left:0px;top:0px;"/></div><div id="spr2_36535a3" class="kern slide"><img id="img0_36535a3" src="data/img27.png" width="1214.256" height="206.956" alt="" style="left:35.001px;top:22.769px;"/><div id="spr3_36535a3" style="left:57.36px;top:45.517px;"><div style="width:0px;"><span id="txt0_36535a3" data-width="802.933594" style="left:184.909px;top:-1.562px;">Co-development challenges</span></div></div><div id="svg6_36535a3" style="left:231.796px;top:157.487px;"><svg width="821" height="5" viewBox="-2.333 -1.167 821 5"><g fill="#d9d9d9" stroke="none"><path stroke="#d9d9d9" stroke-width="2.333" stroke-linecap="butt" transform="translate(-234.128906,-158.654007)" d="M234.129,159.821 H1050.129"/></g></svg></div><div id="spr4_36535a3" style="left:665.532px;top:267.2px;"><img id="img1_36535a3" src="data/img28.png" width="572.25" height="278.25" alt="Diagram  Description automatically generated" style="left:0.206px;top:-0.166px;"/></div><div id="svg9_36535a3" style="left:636.796px;top:272.634px;"><svg width="11" height="384" viewBox="0 -0 11 384"><g fill="#595959" stroke="none"><path transform="matrix(-0,1,-1,-0,5.333374,0)" d="M0,-5.333 h384 v3.556 h-384 Z M0,1.778 h384 v3.556 h-384 Z"/></g></svg></div><div id="spr5_36535a3" style="left:49.442px;top:287.248px;"><img id="img2_36535a3" src="data/img29.png" width="572.25" height="238.5" alt="A picture containing diagram  Description automatically generated" style="left:0.206px;top:-0.296px;"/></div><div id="spr6_36535a3" style="left:668.454px;top:547.831px;"><div style="width:0px;"><span id="txt1_36535a3" data-width="444.080719" style="left:9.6px;top:5.747px;">CDx development and regulation concomitant with Rx</span></div><div style="width:0px;"><span id="txt2_36535a3" data-width="555.187500" style="left:9.6px;top:28.147px;">development and regulation. The relationship between an Rx and a</span></div><div style="width:0px;"><span id="txt3_36535a3" data-width="456.540344" style="left:9.6px;top:50.547px;">CDx is unique and economic effects of co-development</span></div><div style="width:0px;"><span id="txt4_36535a3" data-width="231.391922" style="left:9.6px;top:72.947px;">have yet to be fully realised.</span></div></div><div id="spr7_36535a3" style="left:665.533px;top:648px;"><div style="width:0px;"><span id="txt5_36535a3" data-width="481.145935" style="left:9.6px;top:5.612px;">Luo, et al. 2016.A Quantitative Assessment of Factors Affecting the</span></div><div style="width:0px;"><span id="txt6_36535a3" class="relpos" data-width="202.778748" style="left:9.6px;top:24.812px;">Technological Development</span> <span id="txt7_36535a3" class="relpos" data-width="241.015625" style="left:9.593px;top:24.812px;"> and Frontiers in Genetics, 6, 357.</span></div><div style="width:0px;"><a id="hl0_36535a3" href="https://doi.org/10.3389/fgene.2015.00357" title="https://doi.org/10.3389/fgene.2015.00357" target="_blank" onclick="document.getElementById(\'coreSpr_6623461\').getCore().processTriggerEffect(this);return document.getElementById(\'coreSpr_6623461\').getCore().gotoLink(this);"><span id="txt8_36535a3" data-width="292.687500" style="left:9.6px;top:44.012px;">https://doi.org/10.3389/fgene.2015.00357</span></a></div></div><div id="spr8_36535a3" style="left:36.591px;top:540.387px;"><div style="width:0px;"><span id="txt9_36535a3" data-width="505.330719" style="left:9.6px;top:5.747px;">The drug–diagnostic co-development model. The upper parts</span></div><div style="width:0px;"><span id="txt10_36535a3" data-width="520.889282" style="left:9.6px;top:28.147px;">illustrate the drug development process and the lower parts the</span></div><div style="width:0px;"><span id="txt11_36535a3" data-width="414.002594" style="left:9.6px;top:50.547px;">parallel CDx development process with an aligned</span></div><div style="width:0px;"><span id="txt12_36535a3" data-width="378.747375" style="left:9.6px;top:72.947px;">regulatory co-approval at the end of Phase III.</span></div></div><div id="spr9_36535a3" style="left:29.557px;top:640.555px;"><div style="width:0px;"><span id="txt13_36535a3" data-width="522.044373" style="left:9.6px;top:5.612px;">Olsen and Jørgensen,. 2014. Companion diagnostics for targeted cancer</span></div><div style="width:0px;"><span id="txt14_36535a3" data-width="492.684998" style="left:9.6px;top:24.812px;">drugs - clinical and regulatory aspects. Frontiers in Oncology, 4, 105.</span></div><div style="width:0px;"><a id="hl1_36535a3" href="https://doi.org/10.3389/fonc.2014.00105" title="https://doi.org/10.3389/fonc.2014.00105" target="_blank" onclick="document.getElementById(\'coreSpr_6623461\').getCore().processTriggerEffect(this);return document.getElementById(\'coreSpr_6623461\').getCore().gotoLink(this);"><span id="txt15_36535a3" data-width="271.140625" style="left:9.6px;top:41.176px;">https://doi.org/10.3389/fonc.2014.00105</span></a></div></div></div></div>', '{"s":[]}');})();